Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2003-03-13
2009-11-10
Graser, Jennifer E (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S282100, C424S193100, C424S192100, C424S185100, C530S350000
Reexamination Certificate
active
07615229
ABSTRACT:
A P4 variant protein that has reduced enzymatic activity and that induces antibody to wild-type P4 protein and/or has good bactericidal activity against non-typableH. influenzae(NTHi) is useful as an active component in an immunogenic composition for humans. Methods of using these proteins, and compositions containing them in combination with additional antigens, are also provided.
REFERENCES:
patent: 4518526 (1985-05-01), Olson
patent: 4542104 (1985-09-01), Stryer et al.
patent: 4554101 (1985-11-01), Hopp
patent: 4599197 (1986-07-01), Wetzel
patent: 4734362 (1988-03-01), Hung et al.
patent: 4777127 (1988-10-01), Suni et al.
patent: 4912094 (1990-03-01), Myers et al.
patent: 5057540 (1991-10-01), Kensil et al.
patent: 5078996 (1992-01-01), Conlon, III et al.
patent: 5091309 (1992-02-01), Schlesinger et al.
patent: 5185440 (1993-02-01), Davis et al.
patent: 5217879 (1993-06-01), Huang et al.
patent: 5219740 (1993-06-01), Miller et al.
patent: 5272257 (1993-12-01), Gupta
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5593972 (1997-01-01), Weiner et al.
patent: 5601831 (1997-02-01), Green et al.
patent: 5698202 (1997-12-01), Ertl et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5723127 (1998-03-01), Scott et al.
patent: 5739118 (1998-04-01), Carrano et al.
patent: 5780601 (1998-07-01), Green et al.
patent: 5837533 (1998-11-01), Boutin
patent: 5955580 (1999-09-01), Green et al.
patent: 6083716 (2000-07-01), Wilson et al.
patent: 6113918 (2000-09-01), Johnson et al.
patent: 6127170 (2000-10-01), Boutin
patent: 6168918 (2001-01-01), Satishchandran et al.
patent: 6207646 (2001-03-01), Krieg et al.
patent: 345242 (1989-12-01), None
patent: 415731 (1991-03-01), None
patent: 462210 (1991-12-01), None
patent: 606921 (1994-07-01), None
patent: 2200651 (1988-08-01), None
patent: WO-90/07936 (1990-07-01), None
patent: WO-91/02805 (1991-03-01), None
patent: WO-90/10458 (1991-12-01), None
patent: WO-92/10578 (1992-06-01), None
patent: WO-92/19265 (1992-11-01), None
patent: WO-93/03769 (1993-03-01), None
patent: WO-93/09239 (1993-05-01), None
patent: WO-93/10218 (1993-05-01), None
patent: WO-93/11230 (1993-06-01), None
patent: WO-93/13202 (1993-07-01), None
patent: WO-93/19191 (1993-09-01), None
patent: WO-93/25234 (1993-12-01), None
patent: WO-93/25698 (1993-12-01), None
patent: WO-94/03622 (1994-02-01), None
patent: WO-94/12649 (1994-06-01), None
patent: WO-94/16737 (1994-08-01), None
patent: WO-94/21792 (1994-09-01), None
patent: WO-94/28938 (1994-12-01), None
patent: WO-95/00655 (1995-01-01), None
patent: WO-95/07994 (1995-03-01), None
patent: WO-95/11984 (1995-05-01), None
patent: WO-95/27044 (1995-10-01), None
patent: WO-95/27069 (1995-10-01), None
patent: WO-96/10038 (1996-04-01), None
patent: WO-99/21591 (1999-05-01), None
patent: WO-99/45966 (1999-09-01), None
patent: WO-00/18434 (2000-04-01), None
patent: WO-00/28061 (2000-05-01), None
patent: WO-00/55335 (2000-09-01), None
patent: WO-01/83692 (2001-11-01), None
Mikayama et al. (Nov. 1993. Proc.Natl.Acad.Sci. USA, vol. 90 : 10056-10060.
Rudinger et al. (Jun. 1976. Peptide Hormones. Biol.Council. pp. 5-7.
Gase et al., “The IppC gene ofStreptococcus equisimilisencodes a lipoprotein that is homologous to the e (P4) outer membrane protein fromHaemophilus influenzae”, Med. Microbiol. Immunol. Jun. 1997 186(1):63-73.
Green et al., “Certain site-directed, nonenzymatically active mutants of theHaemophilus influenzaeP4 lipoprotein are able to elicit bactericidal antibodies”,Infec. &Immun. Jul. 2005 73(7): 4454-4457.
Communication—Supplementary European Search Report in European Application No. EP 03714153, mailed May 24, 2006.
Alvarado-Urbina et al., “Automated synthesis of gene fragments”,ScienceOct. 16, 1981 214:270-274.
Amann et al., “Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins inEscherichia coli”, GeneSep. 30, 1988 69(2):301-315.
Andersen et al., “Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoter”,Cell. Mol. Neurobiol. Oct. 1993 13(5):503-515.
Arbuthnot et al., “In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector”,Human Gene Ther. Aug. 20, 1996 7(13):1503-1514.
Barba et al., “Thymidine kinase-mediated killing of rat brain tumors”,J. Neurosurg. Nov. 1993 79(5):729-735.
Berkner, K.L., “Development of adenovirus vectors for the expression of heterologous genes”,Biotech. Jul.-Aug. 1988 6(7):616-629.
Boshart et al., “A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus”,CellJun. 1985 41(2):521-530.
Caillaud et al., “Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells”,Eur. J. Nuerosci. Oct. 1, 1993 5(10):1287-1291.
Chen et al., “Expression of rat bone sialoprotein promoter in transgenic mice”,J. Bone Miner Res. May 1996 11(5):654-664.
Collins et al., “Molecular sequence comparison and alignment” in Practical Approach Series: Nucleic Acid and Protein Sequence Analysis XVIII, (M.J. Bishop et al., eds.) IRL Press: Oxford, England, UK 1987 pp. 417.
Collins et al., “The significance of protein sequence similarities”,Comput. Appl. Biosci. Mar. 1988 4(1):67-71.
Deich et al., “Cloning of genes encoding a 15,000-dalton peptidoglycan-associated outer membrane lipoprotein and an antigenically related 15,000-dalton protein fromHaemophilus influenzae”, J. Bacteriol. Feb. 1988 170(2):489-498.
Fleischmann et al., “Whole-genome random sequencing and assembly ofHaemophilus influenzaeRd”,ScienceJul. 28, 1995 269(5223):496-512.
Flotte et al., “Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector”,Proc. Natl. Acad. Sci. USANov. 15, 1993 90(22):10613-10617.
Gething et al., “Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene”,NatureOct. 22, 1981 293(5834):620-625.
Gossen et al., “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters”,Proc. Natl. Acad. Sci. USAJun. 15, 1992 (12):5547-5551.
Gossen et al., “Transcriptional activation by tetracyclines in mammalian cells”,ScienceJun. 23, 1995 268(218):1766-1769.
Green et al., “A recombinant non-fatty acylated form of the Hi-PAL (P6) protein ofHaemophilus influenzaeelicits biologically active antibody against both nontypeable and type bH. influenzae”, Infect. Immun. Oct. 1990 58(10):72-3278.
Green et al., “The e(P4) outer membrane protein ofHaemophilus influenzae: Biologic activity of anti-e serum and cloning and sequencing of the structural gene”,Infect. And Immun. Sep. 1991 59(9):3191-3198.
Guzman et al., “Efficient and selective adenovirus-mediated gene transfer into vascular neointima”,CirculationDec. 1993 88(6):2838-2848.
Guzman et al., “Efficient gene transfer into myocardium by direct injection of adenovirus vectors”,CirculationDec. 1993 73(6):1202-1207.
Guzman et al., “Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter”,J. Bacteriol. Jul. 1995 177(14):121-4130.
Hansal et al., “Induction of antigen-specific hyporesponsiveness by transplantation of hemopoietic cells containing an MHC class I transgene regulated by a lymphocyte-specific promoter”,J. Immunol. Aug. 1, 1998 161(3):063-1068.
Harvey et al., “Inducible control of gene expression: prospects for gene therapy”,Curr. Opin. Chem. Biol. Aug. 1998 2(4):512-518.
Henry, “Gene therapy”,Chem. Eng. NewsNov. 26, 2001 79(48):35-41.
Jaffe et al., “Adenovirus-mediated in vivo gene transfer and expression in normal rat liver”,Nat. Genet. Aug. 1992 1(5):372-378.
Kass-Eisler et al., “Quantitative determination
Fletcher Leah D.
Green Bruce A.
Reilly Thomas J.
Smith Arnold L.
Zlotnick Gary W.
Gordon Alan M.
Graser Jennifer E
Howson & Howson LLP
The Curators of the University of Missouri
Wyeth Holdings Corporation
LandOfFree
Mutants of the P4 protein of nontypable Haemophilus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutants of the P4 protein of nontypable Haemophilus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutants of the P4 protein of nontypable Haemophilus... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4062043